Thyroid carcinoma after successful treatment of osteosarcoma: A report of three patients

American Journal of Pediatric Hematology/Oncology

Volumn 23, Issue 5, 2001, Pages 312-315

  Verneris, Michael ^a   Ross McDougall, I ^a   Becton, David ^b   Link, Michael P ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF ARKANSAS AT LITTLE ROCK   (United States)

Author keywords

Osteosarcoma; Second malignant neoplasm; Thyroid carcinoma; Werner syndrome

Indexed keywords

BLEOMYCIN; CISPLATIN; CYCLOPHOSPHAMIDE; DACTINOMYCIN; DOXORUBICIN; METHOTREXATE; VINCRISTINE;

ADOLESCENT; ARTICLE; CANCER RADIOTHERAPY; CASE REPORT; DISEASE ASSOCIATION; FAMILIAL CANCER; FEMALE; GENETIC PREDISPOSITION; HUMAN; MALE; ONSET AGE; OSTEOSARCOMA; PRIORITY JOURNAL; SECOND CANCER; THYROID PAPILLARY CARCINOMA; WERNER SYNDROME;

ADOLESCENT; AMPUTATION; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BLEOMYCIN; BONE NEOPLASMS; CARCINOMA, PAPILLARY; CHEMOTHERAPY, ADJUVANT; CISPLATIN; CYCLOPHOSPHAMIDE; DACTINOMYCIN; DOXORUBICIN; FEMALE; FEMORAL NEOPLASMS; GENETIC PREDISPOSITION TO DISEASE; HUMANS; LUNG NEOPLASMS; LYMPHATIC METASTASIS; MALE; METHOTREXATE; NEOPLASMS, SECOND PRIMARY; NORPREGNENES; OSTEOSARCOMA; REMISSION INDUCTION; THORACOTOMY; THYROID NEOPLASMS; THYROIDECTOMY; VINCRISTINE; WERNER SYNDROME;

EID: 0034924182     PISSN: 01928562     EISSN: None     Source Type: Journal    
DOI: 10.1097/00043426-200106000-00016     Document Type: Article

References (22)

1. Malkin D, Li FP, Strong LC, et al. Germ line p53 mutations in a familial syndrome of breast cancer, sarcomas, and other neoplasms [see comments]. Science 1990; 250: 1233-8.
2. Chan H, Pratt CB. A new familial cancer syndrome? A spectrum of malignant and benign tumors including retinoblastoma, carcinoma of the bladder and other genitourinary tumors, thyroid adenoma, and a probable case of multifocal osteosarcoma. J Natl Cancer Inst 1977; 58: 205-7.
3. Camiel MR, Mule JE, Alexander LL, et al. Association of thyroid carcinoma with Gardner’s syndrome in siblings. N Engl J Med 1968; 278: 1056-8.
4. Schuchardt Jr., WA, Ponsky JL. Familial polyposis and Gardner’s syndrome. Surg Gynecol Obstet 1979; 148: 97-103.
5. de Vathaire F, Hawkins M, Campbell S, et al. Second malignant neoplasms after a first cancer in childhood: temporal pattern of risk according to type of treatment. Br J Cancer 1999; 79: 1884-93.
6. Hawkins MM, Draper GJ, Kingston JE. Incidence of second primary tumors among childhood cancer survivors. Br J Cancer 1987; 56: 339-47.
7. de Vathaire F, Schweisguth O, Rodary C, et al. Long-term risk of second malignant neoplasm after a cancer in childhood. Br J Cancer 1989; 59: 448-52.
8. Blatt J, Olshan A, Gula MJ, et al. Second malignancies in very-long-term survivors of childhood cancer. Am J Med 1992; 93: 57-60.
9. Meadows AT, Baum E, Fossati-Bellani F, et al. Second malignant neoplasms in children: an update from the Late Effects Study Group. J Clin Oncol 1985; 3: 532-8.
10. van Leeuwen FE. Risk of acute myelogenous leukaemia and myelodysplasia following cancer treatment. Baillieres Clin Haematol 1996; 9: 57-85.
11. Smith MB, Xue H, Strong L, et al. Forty-year experience with second malignancies after treatment of childhood cancer: analysis of outcome following the development of the second malignancy. J Pediatr Surg 1993; 28: 1342-9.
12. Pratt CB, Meyer WH, Luo X, et al. Second malignant neoplasms occuring in survivors of osteosarcoma. Cancer 1997; 80: 960-5.
13. Nicholson HS, Mulvihill JJ, Byrne J. Late effects of therapy in adult survivors of osteosarcoma and Ewing’s sarcoma [see comments]. Med Pediatr Oncol 1992; 20: 6-12.
14. Russo CL, McIntyre J, Goorin AM, et al. Secondary breast cancer in patients presenting with osteosarcoma: possible involvement of germline p53 mutations. Med Pediatr Oncol 1994; 23: 354-8.
15. Black P, Straaten A, Gutjahr P. Secondary thyroid carcinoma after treatment of childhood cancer. Med Pediatr Oncol 1998; 31: 91-5.
16. Hancock SL, Cox RS, McDougall IR. Thyroid diseases after treatment of Hodgkin’s disease. N Engl J Med 1991; 325: 599-605.
17. Jimenez M, Leon P, Castro L, et al. Second tumors in pediatric oncologic patients. Report of 5 cases. Rev Med Univ Navarra 1995; 40: 72-7.
18. Yen BC, Kahn H, Schiller AL, et al. Multiple hamartoma syndrome with osteosarcoma. Arch Pathol Lab Med 1993; 117: 1252-4.
19. Goto M, Miller RW, Ishikawa Y, et al. Excess of rare cancers in Werner syndrome (adult progeria). Cancer Epidemiol Biomarkers Prev 1996; 5: 239-46.
20. Yu CE, Oshima J, Fu YH, et al. Positional cloning of the Werner’s syndrome gene [see comments]. Science 1996; 272: 258-62.
21. Ishikawa Y, Sugano H, Matsumoto T, et al. Unusual features of thyroid carcinomas in Japanese patients with Werner syndrome and possible genotype-phenotype relations to cell type and race. Cancer 1999; 85: 1345-52.
22. Tsuchiya H, Tomita K, Ohno M, et al. Werner’s syndrome combined with quintuplicate malignant tumors: a case report and review of literature data. Jpn J Clin Oncol 1991; 21: 135-42.